SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is experiencing intense volatility and downward pressure following the announcement of a $7 billion capital raise intended to fund a $39 billion backlog of AI server orders. The community remains deeply divided, with many debating whether this massive dilution represents a necessary strategic move to secure components for hyper-growth or a long-term erosion of shareholder value amid lingering trust and governance concerns.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is currently seeing intense community debate as investors weigh the stock's role as a major AI infrastructure player against recent volatility driven by broader market rotations and concerns over heavy debt and capital expenditures. While some bulls are accumulating shares ahead of upcoming earnings, pointing to a massive backlog and strong institutional price target upgrades, others are expressing caution over potential downside risks and the sustainability of the current AI-led valuation cycle.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is experiencing significant downward pressure as investors rotate into riskier assets and navigate heightened volatility stemming from geopolitical tensions and economic data. The community is actively debating whether gold still functions as an effective inflation hedge, with many users expressing frustration over recent price declines while others view the pullback as a potential buying opportunity.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is experiencing high volatility as investors navigate conflicting news cycles between ongoing military escalations in the Middle East and recurring, yet frequently debunked, rumors of an imminent peace deal. The community is actively debating the durability of the current supply-demand imbalance, with many expressing skepticism toward government-led market suppression and the long-term impact of depleted strategic reserves on oil prices.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging on strong community sentiment fueled by positive Phase 1 data for subcutaneous Briumvi in Myasthenia Gravis and ongoing buyout speculation. Investors are closely watching for potential acquisition interest as the company expands its market potential and strengthens its commercial position.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is experiencing significant volatility driven by the recent release of a shelf registration filing, which prompted concerns regarding potential share dilution among traders. The community remains divided, with many viewing the dip as a strategic accumulation opportunity to bet on long-term national security and domestic supply chain themes, while others are bracing for further downward pressure as they watch key technical support levels.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is gaining significant investor attention as a critical infrastructure "picks and shovels" play for the AI-driven data center boom, with the community highlighting its strong backlog and relative strength during market pullbacks. Investors are actively debating the company's role in addressing power distribution bottlenecks, while comparing its growth trajectory to established leaders in the grid and electrical infrastructure space.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors react to strong growth data for its Predictions platform, which has seen a surge in trading volume and is viewed by some as a key catalyst for expansion into states where traditional sports betting remains restricted. While the community is actively debating the stock's long-term potential versus persistent institutional selling, sentiment is further fueled by high option volume and expectations that upcoming global sports events will drive user engagement.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense downward pressure and widespread community frustration as the stock continues to drop sharply without a clear fundamental catalyst, leading many investors to debate whether the recent sell-off is a systematic liquidation or a long-term accumulation opportunity. Traders are actively discussing the stock's lack of participation in broader market rallies, with many debating the impact of AI infrastructure spending and the potential for a deeper decline toward support levels near four hundred dollars.

Cracker Barrel Old Country Store, Inc. engages in the operation and development of restaurant and retail outlets. The format of its stores consists of a trademarked rustic old country-store design that offers restaurant menu featuring home-style country food. The company was founded by Dan W. Evins on September 19, 1969 and is headquartered in Lebanon, TN.

Cracker Barrel Old Country Store Inc

Cracker Barrel is currently under intense scrutiny following earnings that fell short of expectations, with investors expressing significant frustration over declining traffic, ineffective rebranding efforts, and ongoing leadership concerns. The stock remains a battleground for retail investors, who are actively debating the viability of a turnaround versus the potential for further downside as short sellers maintain a heavy presence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

J&J to Expand Cancer Pipeline With $1B Firefly Bio Acquisition

JNJ is set to acquire Firefly Bio for $1 billion in cash, adding its Firelink DAC platform and advancing efforts in KRAS-driven cancer treatments.

PFE Gets FDA Nod for Expanded Use of Hemophilia Drug Hympavzi

Pfizer wins FDA approval to expand Hympavzi's use in additional hemophilia A and B patient groups, including children with inhibitors.

CORT Stock Rises 42% in a Month: Here's What You Should Know

Corcept shares surge 42% in a month as relacorilant advances in Cushing's syndrome and Lifyorli approval to expand the company's revenue base.

Here's Why Investors Should Hold on to Teladoc Health Stock for Now

TDOC gains on Integrated Care growth, international expansion and cost cuts, but BetterHelp weakness and ongoing losses remain key challenges.

ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs 

Alvotech shares surge after the company resubmits FDA applications for its biosimilar candidates, AVT05 and AVT06, with reviews expected within six months.

Amneal Stock Up on FDA Nod for Romidepsin Injection Solution

AMRX gains after FDA approval of ready-to-use romidepsin injection, with 180-day exclusivity and a potential boost to its injectables portfolio.

RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?

Rezolute rises 38% in a week after interim upLIFT data shows most tumor HI patients cut or eliminate IV glucose support.

Alnylam Bets on AI for Speedy RNAi Drug Discovery and Development

ALNY teams up with Inceptive in a deal worth up to $2B, using AI models and proprietary RNAi data to speed drug discovery and improve candidate selection.

Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know

KOD surges on positive phase III Zenkuda data, accelerated regulatory plans, advancing late-stage programs and a strengthened balance sheet.

SYRE Completes Enrollment in SKYWAY Basket Study on SPY072, Stock Up

Spyre Therapeutics gains after completing enrollment in all SKYWAY phase II sub-studies evaluating SPY072 across three rheumatic diseases.

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA.

Current Price	$38.26
Prev Close	$37.39
Open	$37.99
Dividend Yield	0.00%
50-Day Moving Average	$35.12
Beta	0.84
Avg. Volume	2.2M
PE Ratio	19.38

52-Week High	$41.00
52-Week Low	$13.45
Market Capitalization	$4.56B
EPS (Annual)	$1.64
Price to Book	-32.41
Revenue Per Employee	$1.48M

INDVIndivior Plc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INDV News